Dana-Farber Cancer Institute: Scientists Identify Factors for Predicting Which Patients With Ovarian Cancer Won't Benefit From Immunotherapy-PARP Inhibitor Combination

Press/media: !!Press / Media

Period20 mar 2020

Mediabevakning

1

Mediabevakning

  • TitelDana-Farber Cancer Institute: Scientists Identify Factors for Predicting Which Patients With Ovarian Cancer Won't Benefit From Immunotherapy-PARP Inhibitor Combination
    Medianamn/-företagTargeted News Service
    LandFörenta Staterna (USA)
    Datum20/03/2020
    PersonerSampsa Hautaniemi